Home Cart 0 Sign in  
X

[ CAS No. 58483-95-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 58483-95-7
Chemical Structure| 58483-95-7
Chemical Structure| 58483-95-7
Structure of 58483-95-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 58483-95-7 ]

Related Doc. of [ 58483-95-7 ]

Alternatived Products of [ 58483-95-7 ]

Product Details of [ 58483-95-7 ]

CAS No. :58483-95-7 MDL No. :MFCD06659499
Formula : C6H5ClN2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :WCZUTMZMEAPPIX-UHFFFAOYSA-N
M.W : 172.57 Pubchem ID :22736791
Synonyms :

Calculated chemistry of [ 58483-95-7 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 40.61
TPSA : 76.21 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.49 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.89
Log Po/w (XLOGP3) : 1.21
Log Po/w (WLOGP) : 1.02
Log Po/w (MLOGP) : -1.1
Log Po/w (SILICOS-IT) : 0.68
Consensus Log Po/w : 0.54

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.01
Solubility : 1.69 mg/ml ; 0.00978 mol/l
Class : Soluble
Log S (Ali) : -2.41
Solubility : 0.676 mg/ml ; 0.00392 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.65
Solubility : 3.85 mg/ml ; 0.0223 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.65

Safety of [ 58483-95-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 58483-95-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 58483-95-7 ]
  • Downstream synthetic route of [ 58483-95-7 ]

[ 58483-95-7 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 6313-33-3 ]
  • [ 58483-95-7 ]
  • [ 171178-47-5 ]
YieldReaction ConditionsOperation in experiment
88% With sodium acetate In 2-methoxy-ethanol at 120℃; for 6 h; A mixture of compound 5-amino-2-chloropyridine-4-carboxylic acid(1000 g, 5.8 mol) was dissolved in 5000 mlEthylene glycol monomethyl ether, AddedFormamidine hydrochloride(1867 g, 23.2 mol), sodium acetate (2360 g, 17.4 mol). The reaction was heated to 120 ° C for 6 hours. After the reaction was complete, the reaction was cooled to room temperature, poured into 4000 ml of water and extracted twice with ethyl acetate. The organic phase was combined, dried and concentrated to afford the crude product which was filtered to give 6-chloropyridine And [3,4-d] pyrimidin-4 (3H) ketone (924 g, 5-1 mol)
Reference: [1] Patent: CN104130256, 2016, B, . Location in patent: Paragraph 0027; 0028; 0030
  • 2
  • [ 58483-95-7 ]
  • [ 463-52-5 ]
  • [ 171178-47-5 ]
YieldReaction ConditionsOperation in experiment
81.5% at 120℃; for 4 h; Step 1: containing 1.3 g of 5-amino-2-chloro nicotinic acid (7.6 mmol) and 0.66 g methyl acyl imide amide (formimidamide) (15.1 mmol, 2.0 equiv.) Of acetic acid was heated to 120 acid to give 6-chloro-pyrrolo for 4 hours, the solvent is removed after the addition of an aqueous solution containing sodium hydrogen carbonate solution is adjusted to a value of 8, filtered, and then [3,4-d] pyrimidin -4 (3H) - one (1.1 g, yield 81.5percent).
Reference: [1] Patent: TWI525093, 2016, B, . Location in patent: Page/Page column 93
  • 3
  • [ 58483-95-7 ]
  • [ 171178-47-5 ]
Reference: [1] Patent: US5654307, 1997, A,
  • 4
  • [ 77287-34-4 ]
  • [ 58483-95-7 ]
  • [ 171178-47-5 ]
YieldReaction ConditionsOperation in experiment
83.9% at 140℃; Step (e): 6-CHLORO-3H-PYRIDO [3, 4-D] PYRIMIDIN-4-ONE A suspension of 5-amino-2-chloro-isonicotinic acid in formamide (240 mL) was heated at an internal temperature of 140°C overnight with stirring. The mixture was cooled to room temperature, diluted with water (600mL), and stirred for 1 hour. The resulting solid was collected by filtration, washed with water, and dried to give 17. 20g of 6-chloro-3H-pyrido [3, 4-d] PYRIMIDIN-4-ONE as a brown solid (83. 9percent yield). 1H NMR (400 MHz, DMSO-D6) d ppm 7.9 (s, 1H), 8.2 (s, 1H), 8.9 (s, 1H), 12.7 (bs, 1H) MS (APCI) M+1 = 182.0
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1996, # 18, p. 2221 - 2226
[2] Patent: WO2005/16926, 2005, A1, . Location in patent: Page/Page column 116
[3] Journal of Medicinal Chemistry, 2014, vol. 57, # 8, p. 3484 - 3493
[4] Patent: WO2010/94695, 2010, A1, . Location in patent: Page/Page column 35
  • 5
  • [ 3473-63-0 ]
  • [ 58483-95-7 ]
  • [ 171178-47-5 ]
YieldReaction ConditionsOperation in experiment
92% for 18 h; Heating / reflux Step (e) 6-Chloro-3H-pyrido [3,4-d] pyrimidin-4-one A 1 L round bottomed flask was charged with 5-amino-2-chloro- isonicotinic acid (69.5 g, 0.40 moles), formamidine acetate (84 g, 0.81 moles, 2 mole equivalents), and 600 mL of methoxyethanol. The resulting solution was heated at reflux for 18 hours. After cooling to 5°C, a precipitate was collected by filtration, washed twice with methoxyethanol, and dried overnight in the vacuum oven at 45°C. The reaction yielded 67 g (92percent total yield) of 6-chloro-3H- pyrido [3, 4-D] PYRIMIDIN-4-ONE as a tan solid that was sufficiently pure by NMR to use in the next reaction. 8H (DMSO) 12.70 (1 H, s), 8.86 (1 H, d), 8. 19 (1 H, s), 7.93 (1 H, d) MS [M+H3+ 182
Reference: [1] Patent: WO2005/16926, 2005, A1, . Location in patent: Page/Page column 123-124
[2] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 11, p. 1401 - 1405
  • 6
  • [ 171178-46-4 ]
  • [ 58483-95-7 ]
YieldReaction ConditionsOperation in experiment
87% With trifluoroacetic acid In dichloromethane 5-Amino-2-chloropyridine-4-carboxylic acid.
A stirred suspension of 5-[N-(tert-butoxycarbonyl)amino]-2-chloropyridine-4-carboxylic acid (1.91 g, 7 mmol) in CH2 Cl2 (200 mL) is treated slowly with trifluoroacetic acid until homogeneous (ca. 12 mL).
The solution is stirred overnight and extracted with dilute NH4 OH, and the aqueous layer is then acidified with dilute HCl to gave a precipitate of 5-amino-2-chloropyridine-4-carboxylic acid (1.05 g, 87percent yield).
1 H NMR (DMSO) δ 9.01 (2H, m), 8.03 (1H, s), 7.48 (1H, s).
80% With trifluoroacetic acid In dichloromethane at 20℃; Step (d): 5-AMINO-2-CHLORO-ISONICOTINIC acid A suspension of 5-tert-butoxycarbonylamino-2-chloro-isonicotinic acid in methylene chloride (600mL) was treated dropwise at room temperature with TFA until the solid had dissolved into solution (95 mL). The reaction mixture was stirred overnight under nitrogen at room temperature, evaporated to dryness, diluted with water, and the solid collected by filtration. The solid was washed with water, dried under low heat and house vacuum, to afford 19.55g of 5-amino- 2-chloro-isonicotinic acid as a yellow solid (93.6percent yield). 1H NMR (400 MHz, DMSO-D6) 8 ppm 7.5 (s, 2H), 8.0 (s, 2H) MS (APCI) M+1= 173.0; Step (d): 5-AMINO-2-CHLORO-ISONICOTINIC acid A 3 L round bottomed flask was charged with 5-tert- BUTOXYCARBONYLAMINO-2-CHLORO-ISONICOTINIC acid (138 g, 0.51 moles), 1 L of CH2C12, and 400 mL of TFA. The resulting orange solution was stirred overnight at room temperature. One liter of H20 was added to the reaction solution, which caused a solid to precipitate out. The solid was collected, washed once with H2O and dried overnight in the vacuum oven at 45°C. The reaction yielded 69.6 g (80percent total yield) of 5-amino-2-chloro-isonicotinic acid as a pale yellow solid, which was pure enough by NMR to use in the next reaction. ON (DMSO) 7.99 (1 H, d), 7.45 (1 H, d) MS [M+H] + 173
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1996, # 18, p. 2221 - 2226
[2] Patent: US5654307, 1997, A,
[3] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 11, p. 1401 - 1405
[4] Patent: WO2005/16926, 2005, A1, . Location in patent: Page/Page column 115-116; 123
[5] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 3, p. 256 - 261
[6] Patent: WO2008/130021, 2008, A2, . Location in patent: Page/Page column 405-406
  • 7
  • [ 171178-45-3 ]
  • [ 58483-95-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 11, p. 1401 - 1405
[2] Journal of the Chemical Society - Perkin Transactions 1, 1996, # 18, p. 2221 - 2226
[3] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 3, p. 256 - 261
[4] Patent: WO2008/130021, 2008, A2,
  • 8
  • [ 5350-93-6 ]
  • [ 58483-95-7 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1996, # 18, p. 2221 - 2226
[2] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 3, p. 256 - 261
[3] Patent: WO2008/130021, 2008, A2,
  • 9
  • [ 1072-98-6 ]
  • [ 58483-95-7 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 3, p. 256 - 261
  • 10
  • [ 5326-23-8 ]
  • [ 58483-95-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 11, p. 1401 - 1405
  • 11
  • [ 58483-95-7 ]
  • [ 18107-18-1 ]
  • [ 1073182-59-8 ]
Reference: [1] Patent: WO2008/130021, 2008, A2, . Location in patent: Page/Page column 406-407
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 58483-95-7 ]

Chlorides

Chemical Structure| 58484-01-8

[ 58484-01-8 ]

3-Amino-2,6-dichloroisonicotinic acid

Similarity: 0.83

Chemical Structure| 6313-54-8

[ 6313-54-8 ]

2-Chloroisonicotinic acid

Similarity: 0.82

Chemical Structure| 1060811-65-5

[ 1060811-65-5 ]

4-Amino-6-chloronicotinic acid

Similarity: 0.80

Chemical Structure| 883107-62-8

[ 883107-62-8 ]

Methyl 3-amino-2,6-dichloroisonicotinate

Similarity: 0.78

Chemical Structure| 1256785-40-6

[ 1256785-40-6 ]

Methyl 4-amino-6-chloronicotinate

Similarity: 0.77

Amines

Chemical Structure| 58484-01-8

[ 58484-01-8 ]

3-Amino-2,6-dichloroisonicotinic acid

Similarity: 0.83

Chemical Structure| 88482-17-1

[ 88482-17-1 ]

5-Amino-2-methylisonicotinic acid

Similarity: 0.82

Chemical Structure| 55279-30-6

[ 55279-30-6 ]

Methyl 3-aminoisonicotinate

Similarity: 0.81

Chemical Structure| 1060811-65-5

[ 1060811-65-5 ]

4-Amino-6-chloronicotinic acid

Similarity: 0.80

Chemical Structure| 883107-62-8

[ 883107-62-8 ]

Methyl 3-amino-2,6-dichloroisonicotinate

Similarity: 0.78

Carboxylic Acids

Chemical Structure| 58484-01-8

[ 58484-01-8 ]

3-Amino-2,6-dichloroisonicotinic acid

Similarity: 0.83

Chemical Structure| 6313-54-8

[ 6313-54-8 ]

2-Chloroisonicotinic acid

Similarity: 0.82

Chemical Structure| 88482-17-1

[ 88482-17-1 ]

5-Amino-2-methylisonicotinic acid

Similarity: 0.82

Chemical Structure| 1060811-65-5

[ 1060811-65-5 ]

4-Amino-6-chloronicotinic acid

Similarity: 0.80

Chemical Structure| 58483-94-6

[ 58483-94-6 ]

3-Amino-2-chloroisonicotinic acid

Similarity: 0.76

Related Parent Nucleus of
[ 58483-95-7 ]

Pyridines

Chemical Structure| 58484-01-8

[ 58484-01-8 ]

3-Amino-2,6-dichloroisonicotinic acid

Similarity: 0.83

Chemical Structure| 6313-54-8

[ 6313-54-8 ]

2-Chloroisonicotinic acid

Similarity: 0.82

Chemical Structure| 88482-17-1

[ 88482-17-1 ]

5-Amino-2-methylisonicotinic acid

Similarity: 0.82

Chemical Structure| 55279-30-6

[ 55279-30-6 ]

Methyl 3-aminoisonicotinate

Similarity: 0.81

Chemical Structure| 1060811-65-5

[ 1060811-65-5 ]

4-Amino-6-chloronicotinic acid

Similarity: 0.80